A detailed history of Cutler Group LP transactions in Reviva Pharmaceuticals Holdings, Inc. stock. As of the latest transaction made, Cutler Group LP holds 3,043 shares of RVPH stock, worth $3,864. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,043
Previous 3,043 -0.0%
Holding current value
$3,864
Previous $15,000 26.67%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 18, 2024

BUY
$3.56 - $6.04 $5,137 - $8,715
1,443 Added 90.19%
3,043 $15,000
Q3 2023

Nov 07, 2023

BUY
$3.91 - $5.9 $6,256 - $9,440
1,600 New
1,600 $7,000

Others Institutions Holding RVPH

About REVIVA PHARMACEUTICALS HOLDINGS, INC.


  • Ticker RVPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,442,900
  • Market Cap $26M
  • Description
  • Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is RP506...
More about RVPH
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.